Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Food Policy ; 115:102412, 2023.
Article in English | ScienceDirect | ID: covidwho-2178702

ABSTRACT

Peru increased its sugar-sweetened beverage tax by 8 percentage points (from 17% to 25%) in 2018 and in 2019 imposed front-of-package warning labels on processed and ultra-processed foods and beverages high in sugar, saturated fats, and sodium or containing trans fats. We assess the pre-COVID-19 impacts of these two policies on aggregate formal employment and average wages in the food and beverage industry. In the analysis we use monthly administrative data from the Ministry of Labor in Peru for 127 manufacturing industries from January 2016 through February 2020 and pair an interrupted time series analysis with the synthetic control method. Overall we find that the sugar-sweetened beverage tax increase and the front-of-package label regulations did not result in job or wage losses. These results are consistent with outcomes from previous studies that have separately looked at the effects of sugar-sweetened beverage taxes (in the United States and Mexico) and front-of-package label regulations (in Chile). Our key contribution is that we assess the effects of both policies for the same country. Consistent with the global literature, our findings suggest that, due to industry substitutions and other actions, employment and wages were not impacted even in industries affected by both policies in a short time. The lack of job and wage losses in the Peruvian experience, the scope of the country's policies, and the form of implementation can advise other countries engaging in similar reforms.

4.
Obes Rev ; 22(9): e13301, 2021 09.
Article in English | MEDLINE | ID: covidwho-1249449

ABSTRACT

In 2016, the South African government proposed a 20% sugar-sweetened beverage (SSB) tax. Protracted consultations with beverage manufacturers and the sugar industry followed. This resulted in a lower sugar-based beverage tax, the Health Promotion Levy (HPL), of approximately 10% coming into effect in April 2018. We provide a synthesis of findings until April 2021. Studies show that despite the lower rate, purchases of unhealthy SSBs and sugar intake consumption from SSBs fell. There were greater reductions in SSB purchases among both lower socioeconomic groups and in subpopulations with higher SSB consumption. These subpopulations bear larger burdens from obesity and related diseases, suggesting that this policy improves health equity. The current COVID-19 pandemic has impacted food and nutritional security. Increased pandemic mortality among people with obesity, diabetes, and hypertension highlight the importance of intersectoral public health disease-prevention policies like the HPL, which should be strengthened.


Subject(s)
COVID-19/epidemiology , Health Promotion/methods , SARS-CoV-2 , Sugar-Sweetened Beverages/adverse effects , Sugar-Sweetened Beverages/economics , Taxes , Comorbidity , Consumer Behavior , Diabetes Mellitus/epidemiology , Diabetes Mellitus/prevention & control , Humans , Hypertension/epidemiology , Hypertension/prevention & control , Obesity/epidemiology , Obesity/prevention & control , Socioeconomic Factors , South Africa/epidemiology
6.
Obes Rev ; 21(11): e13128, 2020 11.
Article in English | MEDLINE | ID: covidwho-731029

ABSTRACT

The linkage of individuals with obesity and COVID-19 is controversial and lacks systematic reviews. After a systematic search of the Chinese and English language literature on COVID-19, 75 studies were used to conduct a series of meta-analyses on the relationship of individuals with obesity-COVID-19 over the full spectrum from risk to mortality. A systematic review of the mechanistic pathways for COVID-19 and individuals with obesity is presented. Pooled analysis show individuals with obesity were more at risk for COVID-19 positive, >46.0% higher (OR = 1.46; 95% CI, 1.30-1.65; p < 0.0001); for hospitalization, 113% higher (OR = 2.13; 95% CI, 1.74-2.60; p < 0.0001); for ICU admission, 74% higher (OR = 1.74; 95% CI, 1.46-2.08); and for mortality, 48% increase in deaths (OR = 1.48; 95% CI, 1.22-1.80; p < 0.001). Mechanistic pathways for individuals with obesity are presented in depth for factors linked with COVID-19 risk, severity and their potential for diminished therapeutic and prophylactic treatments among these individuals. Individuals with obesity are linked with large significant increases in morbidity and mortality from COVID-19. There are many mechanisms that jointly explain this impact. A major concern is that vaccines will be less effective for the individuals with obesity.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Coronavirus Infections/physiopathology , Obesity/epidemiology , Obesity/physiopathology , Pneumonia, Viral/epidemiology , Pneumonia, Viral/physiopathology , COVID-19 , Comorbidity , Humans , Internationality , Pandemics , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL